Changes in C-reactive protein, erythrocyte sedimentation rate, human leukocyte antigen-B27, and immunoglobulins A, G, M in patients with ankylosing spondylitis

1. Sharip A, Kunz J. Understanding the Pathogenesis of Spondyloarthritis. Biomolecules. 2020;10(10):1461. DOI: 10.3390/biom10101461Search in Google Scholar

2. Bansal P, Rich T. Dural ectasias in ankylosing spondylitis. Clin Rheumatol. 2021;40(1):421-2. DOI: 10.1007/s10067-020-05348-1Search in Google Scholar

3. Voruganti A, Bowness P. New developments in our understanding of ankylosing spondylitis pathogenesis. Immunology. 2020;161(2):94-102. DOI: 10.1111/imm.13242Search in Google Scholar

4. Xu Y, Jiang W, Zhang H. Association between C-reactive protein gene variant and treatment efficacy of etanercept in ankylosing spondylitis patients receiving hip arthroplasty. J Clin Lab Anal. 2020;34(8):e23343. DOI: 10.1002/jcla.23343Search in Google Scholar

5. Paç Kısaarslan A, Şahin N, Özdemir Çiçek S, Gündüz Z, Poyrazoğlu H, Düşünsel R. Evaluation of familial Mediterranean fever patients concomitant with juvenile spondyloarthropathy. Mod Rheumatol. 2021;31(3):718-24. DOI: 10.1080/14397595.2020.1812809Search in Google Scholar

6. He D, Wang R, Liang S, Liang D, Xu F, Zeng C, et al. Comparison of secondary IgA nephropathy in patients with ankylosing spondylitis and rheumatoid arthritis. Mod Rheumatol. 2020;30(4):648-56. DOI: 10.1080/14397595.2019.1651493Search in Google Scholar

7. Böröcz K, Simon D, Erdő-Bonyár S, Kovács KT, Tuba É, Czirják L, et al. Relationship between natural and infection-induced antibodies in systemic autoimmune diseases (SAD): SLE, SSc and RA. Clin Exp Immunol. 2021;203(1):32-40. DOI: 10.1111/cei.13521Search in Google Scholar

8. Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, et al. 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Care Res. 2019;71(10):1285-99. DOI: 10.1002/acr.24025Search in Google Scholar

9. van der Heijde D, Gensler LS, Deodhar A, Baraliakos X, Poddubnyy D, Kivitz A, et al. Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study. Ann Rheum Dis. 2020;79(5):595-604. DOI: 10.1136/annrheumdis-2020-216980Search in Google Scholar

10. Poddubnyy D. Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis. Rheumatology. 2020;59(Suppl4):iv6-17. DOI: 10.1093/rheumatology/keaa250Search in Google Scholar

11. Kucuksezer UC, Aktas Cetin E, Esen F, Tahrali I, Akdeniz N, Gelmez MY, et al. The Role of Natural Killer Cells in Autoimmune Diseases. Front Immunol. 2021;12:622306. DOI: 10.3389/fimmu.2021.622306Search in Google Scholar

12. Nordin J, Pettersson M, Rosenberg LH, Mathioudaki A, Karlsson Å, Murén E, et al. Association of Protective HLA-A With HLA-B∗27 Positive Ankylosing Spondylitis. Front Genet. 2021;12:659042. DOI: 10.3389/fgene.2021.659042Search in Google Scholar

13. Wu X, Wu J, Li X, Wei Q, Lv Q, Zhang P, et al. The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients. Front Med. 2021;7:568790. DOI: 10.3389/fmed.2020.568790Search in Google Scholar

14. Kasapoğlu Aksoy M, Altan L, Görükmez O, Güner A, Ayar K. The relationship between CRP gene polymorphism (rs2794521, rs3091244), ASDAS-CRP and ASDAS-ESR in ankylosing spondylitis. Mod Rheumatol. 2020;30(4):715-20. DOI: 10.1080/14397595.2019.1639916Search in Google Scholar

15. Liu G, Hao Y, Yang Q, Deng S. The Association of Fecal Microbiota in Ankylosing Spondylitis Cases with C-Reactive Protein and Erythrocyte Sedimentation Rate. Mediators Inflamm. 2020;2020:8884324. DOI: 10.1155/2020/8884324Search in Google Scholar

16. Proft F, Schally J, Brandt HC, Brandt-Juergens J, Rüdiger Burmester G, Haibel H, et al. Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study. Ther Adv Musculoskelet Dis. 2022;14:1759720X221085951. DOI: 10.1177/1759720X221085951Search in Google Scholar

17. Proft F, Muche B, Spiller L, Rios Rodriguez V, Rademacher J, Weber AK, et al. Performance of the Ankylosing Spondylitis Disease Activity Score based on a quick quantitative C-reactive protein assay in patients with axial spondyloarthritis. Joint Bone Spine. 2020;87(1):69-73. DOI: 10.1016/j.jbspin.2019.07.007Search in Google Scholar

18. Cabibi D, Tarantino G, Barbaria F, Campione M, Craxì A, Di Marco V. Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases. Dig Liver Dis. 2010;42(8):585-92. DOI: 10.1016/j.dld.2009.12.006Search in Google Scholar

19. Wan L, Zhu H, Gu Y, Liu H. Diagnostic value of trait antinuclear antibodies and multiple immunoglobulin production in autoimmune diseases. J Clin Lab Anal. 2018;32(4):e22361. DOI: 10.1002/jcla.22361Search in Google Scholar

20. Zhang T, Yang F, Zuo K, Wang J, Cheng Z, Zhang J. HLA-B27 Negativity Is Associated With Renal Function Decline in Patients With Ankylosing Spondylitis and Secondary IgA Nephropathy. Front Med. 2020;7:89. DOI: 10.3389/fmed.2020.00089Search in Google Scholar

21. Rosenbaum JT, Hamilton H, Weisman MH, Reveille JD, Winthrop KL, Choi D. The Effect of HLA-B27 on Susceptibility and Severity of COVID-19. J Rheumatol. 2021;48(4):621-2. DOI: 10.3899/jrheum.200939Search in Google Scholar

22. Wang G, Kim TH, Li Z, Cortes A, Kim K, Bang SY, et al. MHC associations of ankylosing spondylitis in East Asians are complex and involve non-HLA-B27 HLA contributions. Arthritis Res Ther. 2020;22(1):74. DOI: 10.1186/s13075-020-02148-5Search in Google Scholar